Jump to content
  • Posts

    245
  • Joined

  • Last visited

Clive Flashman

Administrators

Everything posted by Clive Flashman

  1. Event
    Confidentiality is frequently seen as a key barrier to clinicians working effectively with the family and friends of people experiencing a mental health crisis. This half day interactive course examines misconceptions about confidentiality and information sharing and offers suggestions for ways to develop your practice to offer more support and information to family and friends carers so that they are more confident about what they can reasonably do to keep their family member safe. We use the term family carers to mean anyone who is significant to the patient, including biological and non biological family and friends who may or may not live in the same household or even the same country. WHO SHOULD ATTEND This course is suitable for anyone working in Health and Social Care whose work brings them into direct contact with someone experiencing a mental health crisis. This includes psychiatrists, nurses, ED service leads, social workers, occupational therapists who have all benefitted from this training. Price: £234 More information and booking link here.
  2. Event
    There is a great deal of professional and statutory guidance that expects clinicians to involve the families of people during and following an acute mental health crisis. And yet, Coroner’s Prevention of Future Deaths reports, and investigations following homicides when the perpetrator had a diagnosed mental illness, regularly point to the lack of meaningful engagement of the family, the failure to listen to their views, experiences and needs, or to offer them support and information to keep their family member safe. Martha’s rule, which is to be extended to mental health services, will also require good working relationships with families. Making Families Count Life Beyond the Cubicle project was funded by NHS England (HEE South East Region legacy funds). The project’s resources were co-created with patients, family carers and clinicians, tested in eleven NHS Trusts, and independently evaluated. The resources have been shown to encourage clinicians to work well with family and friends in order to improve care, avoid harm and reduce deaths. This training is offered to support Trusts and social care agencies to embed effective working with family carers across their workforce. It is participative and interactive, and explores the key reasons clinicians find it challenging to work well with family carers, with time to share and explore good practice and share experiences of approaches taken to improve patient care and family involvement. The Life Beyond the Cubicle eLearning resources are available free to health and social care professionals via the NHS England eLearning platform. NHS Trusts can download the modules and upload them to their own Learning and Development system. WHO SHOULD ATTEND This course is suitable for anyone working in Health and Social Care whose work brings them into contact with people experiencing mental health crises, and whose role offers opportunities to facilitate group discussions and learning. Price: £354 More information and booking link here.
  3. Event
    Good and clear communication between clinicians, patients/service users and family carers are vital for establishing and maintaining effective working relationships that can keep people who are experiencing mental health crises safe. This interactive half day course uses audio and video case studies and scenarios to explore common barriers to effective communications and what can be done about them. We use the term family carers to mean anyone who is significant to the patient, including biological and non biological family and friends who may or may not live in the same household or even the same country. WHO SHOULD ATTEND This course is suitable for anyone working in Health and Social Care whose work brings them into direct contact with someone experiencing a mental health crisis. This includes but is not limited to psychiatrists, nurses, ED service leads, social workers, occupational therapists and peer support workers. Price: £234 More information and booking link here.
  4. Event
    Good and clear communication between clinicians, patients/service users and family carers are vital for establishing and maintaining effective working relationships that can keep people who are experiencing mental health crises safe. This interactive half day course uses audio and video case studies and scenarios to explore common barriers to effective communications and what can be done about them. We use the term family carers to mean anyone who is significant to the patient, including biological and non biological family and friends who may or may not live in the same household or even the same country. WHO SHOULD ATTEND This course is suitable for anyone working in Health and Social Care whose work brings them into direct contact with someone experiencing a mental health crisis. This includes but is not limited to psychiatrists, nurses, ED service leads, social workers, occupational therapists and peer support workers. Price: £234 More information and booking link here.
  5. Event
    The new NHS England guidance Staying Safe from Suicide; confirms that risk cannot and should not be measured using risk scales, and that any such scales are dangerously misleading. A more helpful and hopeful perspective is to think about the safety of people who might at times feel suicidal. This includes engaging in collaborative safety planning with patients and their family carers. This interactive half day course uses video and audio case studies to examine why safety planning is so important, and explores practical ideas about how meaningful and feasible safety planning can be carried out with family carers. Price: £234 More information and booking link here.
  6. Event
    The new NHS England guidance Staying Safe from Suicide; confirms that risk cannot and should not be measured using risk scales, and that any such scales are dangerously misleading. A more helpful and hopeful perspective is to think about the safety of people who might at times feel suicidal. This includes engaging in collaborative safety planning with patients and their family carers. This interactive half day course uses video and audio case studies to examine why safety planning is so important, and explores practical ideas about how meaningful and feasible safety planning can be carried out with family carers. Price: £195 & VAT (£234) More information and booking link here.
  7. Event
    until
    Digital Health Rewired 2026 is the UK’s biggest digital health expo, bringing together everyone using digital and data to improve health and care. Held on 24-25 March at The NEC Birmingham, the event gathers NHS leaders, care providers, researchers, academics, start-ups, suppliers, and innovators to explore how digital technology supports productivity, equity, and better outcomes. With speakers, inspiring NHS case studies, and cutting-edge solutions, Rewired offers valuable learning and networking opportunities. Whether you’re shaping policy, delivering care, or building digital tools, Rewired is your chance to connect, learn, and lead in transforming health and care through digital innovation and collaboration. Register your place here. Find the full programme here. Follow updates via #Rewired26.
  8. Content Article Comment
    This is what i would refer to as meta data. It is data about the reports (data) that have been submitted. It really tells us very little about the actual incidents - type, who was involved, where they happened, etc. Frankly, it's not very useful at all in terms of understanding the composition of incidents in England.
  9. Content Article
    This blog highlights confusion and anxiety among NHS staff following the rollout of Microsoft Copilot, which many learned about only after gaining access. In the first part, a Patient Safety Manager describes their panic on discovering that Copilot could see confidential files, with little guidance provided to them on what is safe or permitted. They felt NHS advice was vague and risk-shifting, leaving staff uncertain and exposed. Patient Safety Learning's Chief Digital Officer, Clive Flashman invited wider engagement on the issue, revealing inconsistent rollouts across Trusts and a lack of clear, practical support. A LinkedIn discussion drew major attention, prompting resource sharing and calls for stronger national coordination, clearer rules, and better training to ensure safe, confident use of AI tools. In the second part of this blog, Clive offers his insights on these issues, reflects on the wider response and shares some useful links. The senior patient safety manager who shared their concerns with Patient Safety Learning has chosen to remain anonymous, but has given their permission for us to publish their first person reflections. Last week, an email landed in my inbox from “the NHS” announcing that Copilot had officially launched — and that it was free for all NHS staff to use. I’ll admit, I was curious and a bit excited. We hear a lot about AI transforming healthcare, and if there’s something that could make our paperwork lighter and free up more time for patients, I’m all for it. But then reality set in. I clicked the link, logged in with my NHS email, and suddenly there it was: everything. Our shared documents, HR folders, Duty of Candour letters, meeting notes, even files that contained sensitive patient information. My first reaction wasn’t amazement — it was panic. Had I just exposed confidential NHS data to the internet? Was this even allowed? I shut it down immediately and emailed our Information Governance (IG) team. The response I received said: “The NHS uses Copilot for administrative and support tasks, such as drafting emails, summarising meetings, and creating documents in Microsoft 365 applications, to free up staff time for patient care. No patient or staff data should ever be included in Copilot. Staff will be responsible if they choose to input patient or staff information into Copilot.” Reading that, it almost sounded as if the reply had been written by Copilot itself — formal, factual, but not particularly helpful. I still didn’t know what I could safely do on it, or how it might genuinely help me in my day-to-day work. From a front-line perspective, this rollout has felt confusing. We’re constantly reminded about data security and confidentiality — now we’re being handed a tool that seems to see everything, with no real explanation of how it works, what’s off-limits, or how to use it effectively. I can see the potential. If Copilot can really help summarise meetings, draft letters, or tidy up reports, that could save precious hours. But right now, without clear NHS-specific training or guidance, it feels risky to experiment. What staff like me need is practical direction, not just reassurances. We need: Clear, accessible rules about what can and can’t be entered. Examples of everyday, safe tasks Copilot can genuinely help with. Transparency about where the data lives and how it’s protected. Real-world demos showing how it supports our roles — clinical, admin, or managerial. Until then, many of us will continue to tread carefully — not because we fear new technology, but because we understand how critical it is to protect patient data. Feeling alone and uncertain about where to turn, I reached out to Patient Safety Learning — an organisation I trust to listen and take my concerns seriously. If Copilot is meant to help us fly, someone needs to show us where the cockpit is. Patient Safety Learning's response (Clive Flashman, Chief Digital Officer) The first thing I did was reach out to some other NHS frontline staff at other organisations to ask how the rollout of CoPilot had been done at their organisations. Every rollout described was from my perspective, ‘sub-optimal’. My response to the Patient Safety Manager was along the lines of “essentially, your documents are all held in the MS cloud (Azure) and CoPilot is a search/ assistant tool residing in the same space. No information is leaving the MS cloud and it shouldn’t change the role-based access controls that determine what you and others can and can’t see within it.” So, I was able to reassure the Patient Safety Manager that there shouldn’t be an Information Governance issue that should be of concern to them. However, what about the clinical data that CoPilot enables the manager to review? This could include legitimate folders and documents containing things like: complete and draft investigations and reviews into patient safety incidents complaints correspondence and reports coroner’s inquest investigations and submissions to court reports to Trust Quality & Safety Committees and Board reports Many, if not all of these, would contain sensitive patient and staff information. This was at odds with the Trust’s response of "no patient or staff data should ever be included in Copilot. Staff will be responsible if they choose to input patient or staff information into Copilot." Understandably the Patient Safety Manager was concerned that they hadn’t been given any guidance on the use of such data. They felt concerned and vulnerable that using CoPilot to help with administrative efficiency for their role could be personally compromising. This felt a very blaming approach, ‘you get it wrong, and you’re culpable.’ I wasn’t sure who would be able to guide me best on this, so we decided that we’d connect with the NHS hive mind and I wrote a LinkedIn post about this. The post highlighted that more needed to be done to support NHS staff in understanding and using CoPilot – and also understanding what it should not be used for. I asked what others were doing and for their advice. The interest in that post was electric. So far it has had just over 40,000 views and hundreds of reactions and comments. The lead person for CoPilot rollout in NHS England became involved in the conversation, as did people from Microsoft. There were differing views on how the rollouts had been handled, and given the fact that this was all done locally, that’s not surprising. The NHS England had done a significant amount of work with the initial proof of concept (30,000 users) and writing use cases and benefits models (as well as apparently a DCB0129 – where is that?). However, I think the fact that the implementation was largely left to local NHS organisations was a mistake, given the uncertainty and variability in responses we’ve seen. I think that communication briefings should have been handled locally, by arranging webinars, training sessions, FAQ lists etc. It would have been helpful for resource packs to have been developed centrally and informed by the pilot. If this id happen, many frontline staff haven’t seen these resources or made use of them. I updated the LinkedIn post to capture the resources that had been shared in the comments (and in some direct messages to me). If other people have useful resources they’d like to share, please do comment below with the links, or you can email our team at [email protected]. Thank you to all those that shared their experiences, helpful resources and their commitment to ensure every staff member is secure in how they use and benefit from CoPilot. Sherwood Forest Hospitals have a 'Responsible use of M365 Copilot for NHS.net Connect' Guide: https://www.sfh-tr.nhs.uk/media/sajavs1n/co-pilot-responsible-use-of-co-pilot.pdf Resources from Microsoft: https://adoption.microsoft.com/en-gb/copilot/ Staff training resources: https://livesend.microsoft.com/ls/1a365ac1-986b-4ff7-9be0-b9e3a7309501/MQEQhnztYeaVOYy6#/ Microsoft end user self-paced learning: https://support.microsoft.com/en-gb/microsoft-365-copilot An example of role-based training provided by Microsoft (this one is for Clinical Administrators): https://msit.events.teams.microsoft.com/event/3c0b9862-fcc4-4994-b6ce-4d8024900191@72f988bf-86f1-41af-91ab-2d7cd011db47 M365 Copilot and M365 Copilot Chat (Web) Acceptable Use Policy: https://comms-mat.s3.eu-west-1.amazonaws.com/Comms-Archive/M365+Copilot+Acceptable+Use+Policy+v1.1.pdf Data Protection Impact Assessment - NHS.net Connect (formerly NHSmail) M365 Copilot : https://comms-mat.s3.eu-west-1.amazonaws.com/Comms-Archive/NHS.net+Connect+Microsoft+365+Copilot+DPIA+v2.0+(GA).pdf We hope that you find this blog of interest, and it might help the NHS reflect on the balance of directing and supporting Trusts in future AI and technology rollouts. And with so much more promised in the 10 Year Plan, let’s all consider how we can support front line staff to optimise the opportunities for productivity improvement.
  10. News Article
    The Public Accounts Committee (PAC) has warned there is a significant risk that digital solutions are being treated as a “cure-all” in the government’s plans to reduce NHS waiting times. In its latest report, the PAC said despite spending £2.2bn of capital funding on diagnostic transformation and a further £1.0bn on surgical transformation, NHS England (NHSE) has missed its recovery targets by significant margins and too many people are still waiting too long for tests and treatment. The PAC warned that this need for change comes at a time of major structural reform in the NHS, including NHSE being abolished and a 50% headcount cut across integrated care boards (ICBs). It says that these unfunded reforms, which will result in the loss of c. 18,000 administrative posts, could have a significant negative impact on patients and the NHS workforce and will lead to wasted effort. It says the integration and sharing of digital records across the NHS remains a key weakness in the system. It also raises concerns about access to and interoperability between digital resources, as well as issues of hardware availability and connectivity. The PAC calls on NHSE and the Department for Health and Social Care (DHSC) to set out: how the elective care transformation programmes are practically affected by the ‘analogue to digital’ shift in the 10 Year Plan; how it will solve the problem of legacy IT equipment and ensure that the IT systems used in different parts of the NHS are properly connected; and whether the 10 Year Plan itself has sufficient funding to deliver the digital transformation required by the plan. During an oral evidence session in September 2025, Sir Jim Mackey (CEO of NHSE) admitted that record sharing across the system remained a key issue. He said digital foundations have been laid through the electronic patient records (EPR) programme but warned that the landscape is evolving rapidly. Mackey said they needed to work out what role the centre (DHSC) should play in managing the proliferation of health technology being made available to and interacting with the NHS, such as consumer-led health devices. This includes developing a healthy market and moving away from big capital, central bidding processes and into more agile and rapid processes. The PAC also states that it is “sceptical that digital change can satisfactorily reach all patients as there is likely to always be a part of the population who find digital technology and tools too difficult to use”. As TechMarketView commented when the 10 Year Plan was published, with digital platforms like the NHS App becoming increasingly important routes to NHS services and information. Much stronger attention needs to be paid to accessibility and user capability, with a focus on digital inclusion and equity. Although the NHS backlog numbers are showing signs of improvement in some areas, they are still far too high. The structural reforms currently underway risk derailing this progress and disrupting digital transformation efforts. Too often digital solutions, particularly AI, are being seen as a panacea for an effective NHS – these technologies will be transformative, but their true potential will not be achieved without a balanced approach to securing the digital foundations.
  11. News Article
    A 51-year-old woman has said she endured an “agonising” hysteroscopy at University Hospital of Hartlepool after not giving informed consent for the procedure. Dawn Lord attended the hospital in May 2023 expecting only routine blood tests and a discussion about future investigations. As she was leaving, her doctor abruptly suggested carrying out a biopsy. She said she was given no explanation of what this would involve and was “in shock” as she was asked to change for the procedure. During the biopsy, a cervical polyp was removed without warning. Mrs Lord said she repeatedly told staff she was in severe pain but was not offered any pain relief. When the biopsy failed, she was told a hysteroscopy — involving a small camera inserted through the cervix — would be “a better method”. She said she was not informed of what was happening and recalled hearing the doctor say “can’t get it” during the attempt. Despite being given a local anaesthetic, Mrs Lord described the pain as “beyond a scale of one to 10”. She continued to suffer heavy bleeding and intense pain over the following days, even fainting during the night. She complained to the hospital and received an apology five months later, along with £400 compensation. North Tees and Hartlepool NHS Foundation Trust admitted it had not met the “high standard of care” it strives for and said her complaint prompted a review leading to service improvements. The Parliamentary and Health Service Ombudsman said the trust had already apologised and committed to improving how it informs patients about procedures and obtains consent. A hysteroscopy is considered the gold-standard method for diagnosing gynaecological conditions, though the Royal College of Obstetricians and Gynaecologists says a third of patients report severe pain and should be offered appropriate anaesthesia. Full article here.
  12. News Article
    The article discusses concerns about proposed cuts to Integrated Care Boards (ICBs) in the UK and their potential impact on patient safety. ICBs are responsible for coordinating local healthcare services, but recent budget reductions could weaken their capacity to ensure effective oversight and patient safety. Healthcare leaders express alarm that these cuts may exacerbate existing gaps in service oversight and lead to inconsistent quality of care across different regions. The article highlights that, although some improvements have been made in patient safety and local care integration, financial limitations could hinder further progress. Experts warn that reduced resources may impair ICBs' ability to monitor performance, implement safety protocols, and respond to patient feedback, potentially putting vulnerable populations at greater risk. The article cites specific examples where local health entities have successfully tackled safety issues and improved patient outcomes, drawing attention to how vital ICBs are in facilitating such initiatives. The article calls for comprehensive dialogue about the sustainability of funding for ICBs and the significance of ensuring strong oversight mechanisms to protect patient safety. It emphasizes the risk of fragmented care if ICBs struggle to fulfill their responsibilities due to budget cuts and urges policymakers to consider the long-term repercussions on health services and patient welfare. In conclusion, the proposed ICB cuts pose a considerable threat to the current efforts in maintaining uniform patient safety standards and addressing the healthcare needs of diverse populations across the country, necessitating immediate attention from health authorities. Full article here.
  13. News Article
    A new poll found more than two-thirds of GPs are concerned about patient safety Patients have submitted requests about life-threatening conditions on non-urgent forms following changes to online access in GP surgeries, family doctors have said. Since October 1, GP surgeries in England have been required to keep their online consultation platform open during working hours for non-urgent appointment requests, medication queries and admin requests. However, family doctors told Pulse magazine they have received reports from patients about difficulty breathing, rectal bleeding and severe vomiting on the forms, which are designed for non-emergencies. A new poll of 431 GPs and practice managers by Pulse found more than two-thirds (67 per cent) are concerned about patient safety since the change. Read more here in the Independent.
  14. News Article
    Software developed in Cambridge is helping nine hospitals to prioritise care, saving lives and freeing beds sooner Hospitals are using artificial intelligence to select high-risk patients to go to the front of the 7.5 million-long NHS waiting list. Software trained on more than 200 million records in 46 countries considers blood pressure, age, respiratory rate and where a patient lives to give them a risk score. Its introduction is part of increasingly urgent efforts by the health service to manage record numbers of patients stuck on waiting lists for routine treatment. Many will be deteriorating while they wait. This month The Sunday Times revealed that thousands have died, gone blind or suffered serious injuries, including having limbs amputated, because of delays and failures in their care. The problem is costing almost £900 million a year in negligence payouts. The NHS last hit its target to treat most patients within 18 weeks of being referred from their GP in February 2016. Now trusts are experimenting with new ways to balance the risks of such large waiting lists after the pandemic. AI software developed by the Cambridge-based company C2-Ai is being used in nine hospitals in Cheshire and Merseyside; similar tools are being piloted elsewhere. The technology helps identify patients who have a high risk of deteriorating while they wait, or who might struggle to recover after major surgery. These people are given help to improve their health while waiting and can be prioritised for surgery sooner. Almost 1,000 patients have benefited from interventions such as health coaching before and after surgery. The approach has almost eradicated post-op chest infections and halved the rate of other complications. It has also reduced the amount of time patients are staying in hospital by more than four days — meaning beds are free for those waiting in A&E or others needing routine surgery. One of those who is benefiting is Tim Ashcroft, a 74-year-old businessman who was diagnosed with oesophageal cancer in 2023. After six weeks of chemotherapy, Ashcroft, from Winsford, Cheshire, had surgery to remove his oesophagus and possible cancer of the colon. After the surgery he had a stoma — an opening in the abdomen — which led to a double hernia; he was put on a waiting list to have the procedure reversed. Ashcroft had lost five stone since the initial surgery. In October, the C2-Ai technology flagged him as a potential risk and he was given a referral to use a phone app, Surgery Hero, which provides tools for exercise, tracking food intake and mental health support. The app linked Ashcroft with a dietitian who helped manage his nutrition and maintain his weight. They also spoke to consultants to bring forward his surgery, which he is hoping to have in the coming weeks. “It gave me a sense that I can look after my health while I wait, and that’s important especially as waits are so long at the moment,” Ashcroft said. “If this is a process which can generally save time and save lives … I don’t think anyone would object to that.” Rowan Pritchard Jones, medical director of the Cheshire and Merseyside NHS region, said it was right for the NHS to prioritise higher-risk patients. “We really need to think more smartly about the risk that is sitting on our waiting lists,” he said. “Nobody gets better while waiting but there are certain groups of patients who disproportionately deteriorate while they wait — patients whose [mortality risk] might move from 15 per cent to 45 per cent.” According to Cheshire and Merseyside, 40 per cent of its highest risk patients — those living with a number of conditions or diseases at the same time — come from the 20 per cent most deprived members of the population. Pritchard Jones said: “We have patients to worry about here, patients who will do badly. Let’s think about stratifying patients by risk.” C2-Ai’s technology is not the only innovation being tried to spot patients at higher risk from waiting times. In Coventry, the cardiologist Kiran Patel developed an algorithm to identify patients who had higher clinical risks and underlying social and demographic factors that meant they should be prioritised for treatment. It took into account whether a person had made repeat visits to A&E and whether they lived in a deprived area or had other health conditions. Patel, now chief medical officer at University Hospitals Birmingham, believes similar approaches could be considered there. “We know from the evidence that people are dying more from non-pandemic related issues and deprivation of care,” he said. “So that evidence is out there, and the fact that we have long waiting lists, and the fact that there are millions of people on there, would suggest that it’s inevitable some may be dying.” The approach is likely to prove controversial, particularly if it is used to prioritise patients according to factors such as getting them back to work. Jo Andrews, a consultant anaesthetist and chief medical officer at the consultancy Carnall Farrar, said: “If we look at the national challenge around people who are off work sick, we need to go after the things where it’s going to make the greatest difference. “That requires a difficult conversation with people, because you would be saying to the 75-year-old waiting for their hip replacement who can’t play golf, ‘Sorry, you’re going to have to wait a bit longer’, because the 65-year-old who can’t work and is the sole breadwinner for their family needs to take priority.” From The Sunday Times
  15. News Article
    Nearly 5,000 nurses, over 100 physicians, and advanced practitioners at Providence Oregon began striking Friday, impacting all eight state hospitals and six women’s clinics. Striking workers cite systemic understaffing, safety concerns, and job security fears due to Providence’s operational changes and private equity involvement. The Oregon Nurses Association (ONA) has accused Providence of refusing to bargain effectively, leading to the strike after over a year of stalled negotiations. Providence countered, claiming it offered nurses a 20% pay increase and accused the union of stalling. Governor Tina Kotek urged all parties to return to the table, emphasizing the disruption to patient care. Providence has hired 2,000 temporary nurses but struggled to find replacement physicians, consolidating women’s clinic services and reducing capacity. Providence leadership acknowledged challenges but expressed commitment to resuming negotiations once operations stabilise. Full article here.
  16. Content Article
    A set of 5 infographics describing the the factors that influence the risk of nosocomial transmission of infections (such as Covid19), and how health and care staff can take action to manage the risks and reduce the infection rate. The factors explained are: People Equipment Task Environment Organisation These infographics are from the summary HSIB report (22 October 2020) entitled "COVID-19 transmission in hospitals: management of the risk – a prospective safety investigation". The exec report can be found here. They explain the five main aspects related to the nosocomial transmission of infection, and how the risks of this happening can be properly managed.
  17. Content Article
    The advance of artificial intelligence (AI) has seen the emergence of digital diagnostic tools, with some claiming a more accurate diagnosis than a human. But what challenges does this present to patient safety? In this blog, Clive Flashman, Patient Safety Learning's Chief Digital Officer, looks at some of these new digital tools that are becoming  increasingly available not only to clinicians but also for patients, and highlights some of the risks that they bring and considerations that need to be thought through. This blog has been published as part of a series for World Patient Safety Day 2024 and the theme of Improving diagnosis for patient safety. #WPSD24, World Patient Safety Day 2024, WPSD 2024. Why diagnosis is important When you have been feeling unwell for a while despite the over-the-counter remedies that you’ve bought, you try and make an appointment to see your GP. Note that I said ‘try’; getting a GP appointment these days is a bit like a long distance run, with no guarantee that you will cross the finish line anywhere near the time you’d hoped for. When you do see your GP, they will draw on their medical school training, their years of experience, their knowledge of you as their patient (or at least what the medical record they hold about you contains) and, from all of that, determine what might be wrong with you. They might need some additional evidence before confirming that diagnosis—so they might request that you have a blood test or an MRI, etc. Once those results are back, you will be contacted again by the GP (or one of their staff) to tell you what that means for you. Was the original diagnosis correct? Has it changed? How will you be treated? Diagnosis is the starting point for therapeutic treatment The diagnosis is the starting point for therapeutic treatment. Get that wrong and, like a long line of dominos, everything else will fall out of place. We are reliant on this diagnosis to make our recovery (if that is possible) or to at least return to some form of wellness. It is pivotal in the patient’s care pathway and there are around 1.5 million[1] primary care consultations a day, of which 45% are with a GP. It is also critical that the diagnostic test is carried out and the results delivered promptly to give a timely and more accurate diagnosis. Sadly, as of May 2024, 1.66 million[2] people are on the waiting list for a diagnostic test—the highest figure since the current data series started being collected in January 2006. A new model for diagnoses In recent years, advances in AI have seen the emergence of digital diagnostic tools. Perhaps the most well known of these is Babylon Health, once valued at $4.2 billion, which collapsed in 2023 having already pulled out of the NHS contracts it had previously won.[3] Its main competitor for general AI-driven health diagnosis is Ada Health, which features a link to a medical journal (Rheumatology International) on its website that claims that “Ada was more accurate than physicians in suggesting the correct final diagnosis (54% of cases vs physicians' 32%)”.[4] Personally, I’m not sure that even a 54% diagnostic accuracy rate is that great, but compared to an awful 32% for human doctors, it is clearly an improvement. One of the most successful areas where AI has been involved in diagnosis is in the interpretation of medical images. Typically, two radiographers would review the same X-ray and come to individual conclusions about what is being shown, then compare those conclusions to make a final judgement. Studies have shown that where one of those radiographers is replaced by an AI equivalent, the diagnostic accuracy rate is at least as good if not better than before.[5] Many of these tools are for use by clinicians. They are expected to overlay their own judgement on top of the recommendations provided by the digital solution. However, increasingly digital diagnostic tools are being aimed at both patients and clinicians (Ada Health being the most obvious one). For example: MiiCare - blends smart home surveillance, an AI-driven voice assistant and vital signs monitoring to create a unique at-home virtual care solution. Healthy.io – offers standardised digital wound management services that help clinicians make better care decisions using the smartphone camera to accurately capture wounds and analyse their progress. Qure.ai – uses AI algorithms for medical imaging to identify and localise abnormalities on X-rays, MRI and CT scans. Odin Vision – helps clinicians to detect and diagnose polyps during colonoscopy procedures. PocDoc – looks to leverage the ubiquity of smartphones, turning them into personal diagnostic devices able to detect a range of major diseases from a pinprick of blood. Zio by iRhythm – helps clinicians and patients to quickly spot and confirm heart arrythmias. Binah.ai – uses the smartphone camera to calculate vital signs. Its software looks at the region around the eyes, where the skin is a bit thinner, and analyses the light reflecting off blood vessels back to the lens. Canary Speech – uses the same underlying technology as Amazon’s Alexa to analyse patients’ voices for mental health conditions. eMoodie Minds – a digital-first mental health assessment tool. Feebris – used with a digital stethoscope for earlier diagnosis of childhood pneumonia. Home: the new setting for diagnostic tests With the increasing availability of home-based tests from companies such as Thriva, PocDoc, Pinpoint (blood testing) and Healthy.io (urinalysis) —which can all link to smartphone apps to leverage AI algorithms, potentially support diagnoses and track conditions — diagnostic testing at home is becoming more prevalent. This frees up clinician time and clinic space. However, it relies on the patient to perform the test accurately and submit the reading in a complete, timely and accurate manner. Regulatory and ethical guardrails There are a significant number of hurdles that digital health technology suppliers in the UK have to jump before their solutions can be used by doctors or patients. The Medicines and Healthcare Products Regulatory Agency (MHRA) sets strict guidance on the evidence that is required and, in some cases, software will be classed as a medical device[6] and treated with the same regulatory rigour. NICE expects digital health technologies to have involved patients and healthcare professionals in their design and testing, and also to have gathered increasing amounts of evidence about efficacy.[7] This can be anything from a simple impact evaluation to a full randomised control trial, depending on the level of clinical judgement and recommendations the digital solution will be providing. NHS England demands that all NHS buyers of digital health technologies will complete a clinical safety case[9] for each solution they buy and also to complete the DTAC (Digital Technology Assessment Criteria), which considers: clinical safety (again) data protection clinical assurance interoperability usability and accessibility. Challenges However, patients are not trained how to interpret health data[8] and are also potentially at risk if seeing a diagnosis for the first time without adequate support in place. People who are newly diagnosed with a condition generally want to talk it through with a clinician, discuss treatment options, understand the impact it may have on their lives. Being left alone with your diagnosis, and having to then proactively make appointments to discuss it, is not what patient groups might consider the best approach to patient-centred care. Passive data collection, such as through a clinically certified wearable device or skin patch, can be relied upon to provide reasonably accurate data. However, where the patient is expected to conduct their own diagnostic test using their phone, or gathering blood or urine, the reliability of the data collected might be lower. There are also people who are not able to use these types of technologies or tests at home. They may be one of a group of people who are digitally excluded or have impairments (fine motor skills, cognition, visual, etc.) that mean that they cannot use the necessary items. In the same way that many people hate the push by supermarkets to move to self-checkouts where the burden is placed on the shopper to scan their own goods, some people also recoil at the thought of having to do their own medical tests and interpret the results. Conclusion It is inevitable that we will move to see more digital health diagnostics used by healthcare professionals and patients. However, we should not forget that this will not be appropriate for some people and offer other options for them to gain a formal diagnosis. People using digital diagnostic tools should be able to call on support where they need it and the guardrails that we have in place should be continuously reviewed so that they deal with new and innovative technologies before they cause significant harm to users. It is my view that these tools should be smart enough to recognise when a new (significant) diagnosis has been given to the patient and, in those cases, immediately contact a clinician to advise that support should be provided. If that cannot be done, then new diagnoses of this nature should not be communicated directly to a patient. References BMA. Pressures in general practice data analysis, 26 July 2024. Kirk-Wade E, Harker R, Stiebahl S. NHS key statistics: England. House of Commons Library, 16 July 2024. The Fall of Babylon Is a Warning for AI Unicorns. Wired, 19 September 2023. Graf M, Knitza J, Leipe J, et al. Comparison of physician and artificial intelligence-based symptom checker diagnostic accuracy. Rheum Int, 2022:42(12):2167-2176. doi: 10.1007/s00296-022-05202-4. Epub 2022 Sep 10. King's College London. AI trained on X-rays can diagnose medical issues as accurately as doctors, 11 December 2023. MHRA. Guidance. Software and AI as a Medical Device Change Programme - Roadmap. Medicines and Healthcare products Regulatory Agency, 14 June 2023. NICE. Evidence standards framework (ESF) for digital health technologies. NIHR Evidence: Health information: are you getting your message across? June 2022; doi: 10.3310/nihrevidence_51109 NHS England. Digital clinical safety assurance, v 1.1, 28 July 2023. Share your insights What do you think about the digital developments in health that Clive talked about in this blog? Do you have an experience to share as a patient, or as someone who works in this area? If you'd like to share your insights around digital health and patient safety, get in touch with the team at [email protected]. Have you been affected by a late diagnosis? Or perhaps you have insights to share on diagnostic safety through the work that you do. If you would like to write a blog or share your thoughts, experiences or resources through the hub please get in touch with our team at [email protected] or add your comments to our community forum page.
  18. Content Article Comment
    I think it's a good idea but it won't work without the infrastructure to support it and possibly a Citizen ID card. The paper seems to be regurgitating ideas from Estonia etc. without the basics in place to make it happen. If Lord Darzi advocates this within his review there will be a lot of pushback. It will cost significant chunks of money to put the 'basics' in place, which the Government can't seem to afford at the moment. The other key thing that the paper doesn't make as explicit as it should is that the Digital Health Record should be owned by THE PATIENT.
  19. News Article
    C2.AI has formally launched its Maternity and Neonatal Observatory at the NHS ConfedExpo in Manchester (Government and Public Sector Journal). The observatory is intended to give hospitals and clinicians a detailed picture of the performance of maternity units and the health trajectories of individual women, so areas of concern can be identified and acted on. The system works by calculating and comparing observed outcomes for women and babies with expected outcomes for these individuals. To do this, it uses AI and machine learning to assess clinical factors, case-mix, and the social determinants of health. Early adopters within the NHS, where maternity services are under intense scrutiny, are expected soon.
  20. News Article
    Female health monitoring apps are putting women at risk by "coercing" them into disclosing - and then poorly handling - highly sensitive data, according to new research. The study examined the privacy policies and data safety labels of 20 of the most popular of these kind of apps, which are commonly used to help women conceive. It found a host of poor data-management practices, including some apps not having a delete function, even for highly personal information such as menstrual cycles and miscarriages. Its authors say it is the most extensive evaluation its kind completed to date. They say the apps are used by hundreds of millions of people. The BBC has contacted a number of app providers - none have responded to a request for comment. "While female health apps are vital to the management of women’s health worldwide, their benefits are currently being undermined by privacy and safety issues," the lead author of the study, Dr Ruba Abu-Salma, from King's College London, told the BBC. Other key findings from the study include: 35% of apps claimed not to share personal data with third parties but contradicted this in their privacy policies 50% assured users that health data would not be shared with advertisers, but were ambiguous about other data collected 45% of privacy policies denied responsibility for third-party practices, despite claiming to vet them. Female-focused technology has boomed in recent years, with the market expected to exceed $75 billion by 2025. But Lisa Malki, another of the study's authors, said the industry needed to get better at protecting the women whose data it was using. Read full article on the BBC here.
  21. Community Post
    Hi, we at patient Safety Learning are looking to hold a virtual round table in the last week of June to look at how to improve patient safety related to the implementation of EPRs. If you are a clinician who has been directly involved with the roll out of an EPR, then you could be part of the event. All notes taken at the event will follow Chatham House rules and your participation will not be disclosed outside the round table group if that is your preference. If you'd like to be involved, please contact me (Clive Flashman) directly at [email protected] Many thanks, Clive
  22. News Article
    One of the best doctors in the UK died on an understaffed Manchester hospital ward after falling sick with a condition he was an expert in treating, an inquest has heard. Professor Amit Patel was among the ‘best doctors in the UK’, the first person in the country to be qualified in stem cell transplantation and cellular therapy, and intensive care medicine. He was also a beloved husband and father-of-two. “He looked liked a corpse, 70 per cent of his blood was in his lungs, he was freezing cold and he looked like he was dead," his heartbroken wife told an inquest at Manchester Coroners Court. "I told my daughters, ‘daddy is dead’ – I didn’t have much hope he would be able to come out of that.” Professor Patel's condition was being investigated by doctors at Wythenshawe Hospital, Manchester Royal Infirmary, and across the country. But, he was in the unimaginable position of being a nationally recognised expert in the illness. During his career, he had formed ‘national guidance’ on the illness and sat on the national multi-disciplinary panel to which the most serious cases, including his own, were referred. The court heard how he was experiencing the symptoms of hemophagocytic lymph histiocytosis (HLH) – a rare and life-threatening immune disorder where the body reacts inappropriately to a 'trigger’, such as an infection or cancer, and leads to inflammation. Patients can be predisposed to HLH by Still’s disease, another rare autoimmune condition also causing inflammation, which Professor Patel was suspected to have had. Full article here.
  23. News Article
    Presymptom Health’s technology provides early and reliable information about infection status and severity in patients with non-specific symptoms, helping doctors make better treatment decisions. The company’s tests can be run on NHS PCR platforms, which were widely deployed during the COVID pandemic and are now often under-utilised. By detecting true infection and sepsis earlier, it’s possible to save lives and significantly reduce the incorrect use of antibiotics. When it comes to sepsis, Presymptom’s technology could revolutionise treatment. According to The UK Sepsis Trust, every 3 seconds, someone in the world dies of sepsis. In the UK alone, 245,000 people are affected by sepsis with at least 48,000 people losing their lives in sepsis-related illnesses every year. This is more than breast, bowel and prostate cancer combined. When diagnosed at a late stage, the likelihood of death increases by 10% for every hour left untreated. Yet, for many patients, with early diagnosis it is easily treatable. “We’re confident that our first product can play a big part in tackling Anti-Microbial Resistance (AMR), which has been identified by the World Health Organisation as one of the top 10 global public health threats,” said Dr Iain Miller, CEO of Presymptom Health. “By understanding the presence, or absence, of infection as early as possible, doctors can be more confident in their diagnosis and avoid unnecessarily prescribing antibiotics – something that is a growing concern in the NHS and globally. “If we take Sepsis as an example. Sepsis diagnostics hasn’t moved on in more than a century, and currently doctors can only diagnose it when advanced symptoms and organ failure are present – which is often too late. Our technology enables doctors to diagnose both infection and sepsis up to three days before formal clinical diagnosis, radically transforming the process and preventing unnecessary deaths. The science behind Presymptom’s technology is based upon 10 years of work conducted at Defence Science and Technology Laboratory (Dstl) and originated from £16m of sustained Ministry of Defence investment in a programme of research designed to help service personnel survive infection from combat injuries. The technology is currently undergoing clinical trials at nine NHS hospitals in the UK, with results anticipated later in 2024. In addition, Presymptom is working on additional UK and EU trials.
  24. Content Article Comment
    Hi @Kenny Fraser, thanks for taking the time to respond. Yes, not having an EPR is definitely risky as it precludes the sharing of information, certainly within a single organisation. In terms of an assessment, I would guess that something like that was done at the beginning of the National Programme for IT back in 2003, but I've not seen anything more recently. With regard to benefits realisation, this is a useful document to look at: https://www.ouh.nhs.uk/patient-guide/documents/epr-case-study.pdf In terms of the safety reviews that EPRs have to go through, as you can imagine, they are a lot more robust than DTAC. There is an extremely detailed safety hazard assessment that was created by Dr Maureen Baker and others as part of the NPfIT roll out in the mid 2000s. That is where much of the slimmed down DCBs and DTAC material has come from. However, there are limitations to the self-assessed reviews, and there will always be 'snags' picked up post implementation. My key worry is that this 'post-market surveillance' is not sufficiently specified, or generally done, and while DCB0129 and DCB0160 are meant to be repeated also as part of this process, that hardly every happens.
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.